- Home
- LVWR vs CBLL Comparison
LVWR vs CBLL Comparison
Compare LVWR & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVWR
- CBLL
- Stock Information
- Founded
- LVWR 2022
- CBLL 2014
- Country
- LVWR United States
- CBLL United States
- Employees
- LVWR N/A
- CBLL N/A
- Industry
- LVWR
- CBLL
- Sector
- LVWR
- CBLL
- Exchange
- LVWR Nasdaq
- CBLL Nasdaq
- Market Cap
- LVWR 892.3M
- CBLL 762.0M
- IPO Year
- LVWR N/A
- CBLL 2024
- Fundamental
- Price
- LVWR $2.33
- CBLL $24.69
- Analyst Decision
- LVWR Hold
- CBLL Strong Buy
- Analyst Count
- LVWR 1
- CBLL 5
- Target Price
- LVWR $7.25
- CBLL $33.25
- AVG Volume (30 Days)
- LVWR 40.3K
- CBLL 151.6K
- Earning Date
- LVWR 02-05-2025
- CBLL 02-25-2025
- Dividend Yield
- LVWR N/A
- CBLL N/A
- EPS Growth
- LVWR N/A
- CBLL N/A
- EPS
- LVWR N/A
- CBLL N/A
- Revenue
- LVWR $26,633,000.00
- CBLL $60,041,000.00
- Revenue This Year
- LVWR $249.13
- CBLL $44.86
- Revenue Next Year
- LVWR $98.53
- CBLL $26.56
- P/E Ratio
- LVWR N/A
- CBLL N/A
- Revenue Growth
- LVWR N/A
- CBLL 131.62
- 52 Week Low
- LVWR $2.26
- CBLL $18.69
- 52 Week High
- LVWR $9.71
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- LVWR 24.09
- CBLL N/A
- Support Level
- LVWR $2.26
- CBLL N/A
- Resistance Level
- LVWR $2.80
- CBLL N/A
- Average True Range (ATR)
- LVWR 0.23
- CBLL 0.00
- MACD
- LVWR 0.03
- CBLL 0.00
- Stochastic Oscillator
- LVWR 6.60
- CBLL 0.00
About LVWR LiveWire Group Inc.
LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel.
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.